| --- | --- | --- | |-----------------------------|--------------------|-------| | | | | | | | | | | CHEMED CORPORATION | | | | | | | Results as of June 30, 2020 | | | | | | | | | | | | | | care | Safe Harbor and Regulation G Statement This presentation contains information about Chemed's EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and Adjusted Diluted EPS, which are not measures derived in accordance with GAAP and which exclude components that are important to understanding Chemed's f ...

| --- | --- | --- | --- | |------------------------------|--------------------|-------|-------| | | | | | | | | | | | | CHEMED CORPORATION | | | | | | | | | Results as of March 31, 2020 | | | | | | | | | | | | | | | | Healtr | | care | Safe Harbor and Regulation G Statement This presentation contains information about Chemed's EBITDA, Adjusted EBITDA, EBIT, Adjusted EBIT, Adjusted Net Income and Adjusted Diluted EPS, which are not measures derived in accordance with GAAP and which exclude components that ar ...

| --- | --- | |-------|------------------------------------| | | | | (IRS | Employer Identification No.) 45202 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2020 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as speci ...

Chemed Corporation (NYSE:CHE) Q1 2020 Results Earnings Conference Call April 29, 2020 10:00 AM ET Company Participants Sherri Warner - Investor Relations Kevin McNamara - President and Chief Executive Officer David Williams - Executive Vice President and Chief Financial Officer Nicholas Westfall - Executive Vice President; and Chief Executive Officer and Chief Operating Officer, VITAS Healthcare Corporation Conference Call Participants Bradley Bowers - Bank of America Merrill Lynch Frank Morgan - RBC Capita ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from ________ to________ Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati ...

Chemed Corporation (NYSE:CHE) Q4 2019 Earnings Conference Call February 19, 2020 10:00 AM ET Â Company Participants Sherri Warner - Investor Relations Kevin McNamara - President and Chief Executive Officer Dave Williams - Executive Vice President and Chief Financial Officer Nick Westfall - President and Chief Executive Officer, VITAS Healthcare Corporation Conference Call Participants Joanna Gajuk - Bank of America Frank Morgan - RBC Operator Ladies and gentlemen, thank you for standing by and welcome to th ...

| --- | |-------| | | | | | | | | | | | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2019 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incor ...

Chemed Corp (NYSE:CHE) Q3 2019 Earnings Conference Call October 30, 2019 10:00 AM ET Company Participants Sherri Warner - Director, IR Kevin McNamara - CEO, President & Director David Williams - EVP & CFO Nicholas Westfall - CEO & President Conference Call Participants Joanna Gajuk - Bank of America Merrill Lynch Frank Morgan - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by, and welcome to the Chemed Corporation's Third Quarter 2019 Earnings Conference Call. [Operator Instructi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2019 o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 1-8351 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware 31-0791746 (State or other jurisdiction of incorporation or organization) (IRS Emplo ...

Chemed Corporation (NYSE:CHE) Q2 2019 Earnings Conference Call July 26, 2019 10:00 AM ET Company Participants Sherri Warner - IR Kevin McNamara - President and CEO David Williams - EVP and CFO Nicholas Westfall - CEO, VITAS Healthcare Corporation Subsidiary Conference Call Participants Joanna Gajuk - Bank of America Merrill Lynch Frank Morgan - RBC Capital Markets Operator Hello and welcome to the Chemed Corporation Second Quarter 2019 Earnings Call. [Operator Instructions] As a reminder this call is being ...